Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Raja Roti Cemerlang Tbk. (BRRC) vs Merck Tbk. (MERK) Price & Performance

Raja Roti Cemerlang Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Raja Roti Cemerlang Tbk. vs Merck Tbk. — how do they compare? Raja Roti Cemerlang Tbk. trades at Rp63 (market cap 64.65B, 16.91M 24h volume), while Merck Tbk. trades at Rp3,890 (market cap 1.75T, 29.1K 24h volume). The key difference: Merck Tbk. is far larger — about 27.1× Raja Roti Cemerlang Tbk.'s market cap, and Raja Roti Cemerlang Tbk. is more actively traded (16.91M versus 29.1K). Which is the better fit depends on your goals.

BRRCMERK
Market Cap
64.65B1.75T
Volume
16.91M29.1K
Lot
169.09K291
Turnover
1.07B113.37M
Average Price
63.493,895.98
Value
1.07B113.37M
Indicative Equilibrium Price
633,890
Indicative Equilibrium Volume
1.95K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BRRC
View details
MERK
View details

About Raja Roti Cemerlang Tbk.

PT Raja Roti Cemerlang Tbk (the Company) was established based on Notarial Deed No. 5 dated September 21, 2015 of Dian Rohmah Yuniasari, S.H., M.Kn., notary in Bekasi. The Company begin its operation activities in 2015.

Read more on BRRC

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK